IP Verse

Samyang competitive analysis

Latest publications and patents of Samyang New

Explore the latest publications and patents granted to Samyang, showcasing their recent innovations and technological advancements.

Last updated on: Oct 2, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Samyang

EP3295808
Feb 26, 2025Saccharide Mixture Containing Psicose With Improved Sweetness Quality And CrystallizationPatent Maintained As Amended
EP3170855
Jun 9, 2021Polysulfone Copolymer With Excellent Heat Resistance And Chemical Resistance, And Method For Preparing SameRevoked
EP2933256
May 22, 2019Method For Preparing An Anhydrosugar Alcohol Using HydrolGranted And Under Opposition
EP2759294
Nov 1, 2017Percutaneously Absorbable Preparation Containing Fentanyl And A Homologue ThereofRevoked

Latest patents of Samyang opposed by its competitors

Explore Samyang's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 9, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3295808
Feb 26, 2025Saccharide Mixture Containing Psicose With Improved Sweetness Quality And Crystallization1
EP3170855
Jun 9, 2021Polysulfone Copolymer With Excellent Heat Resistance And Chemical Resistance, And Method For Preparing Same2
EP2933256
May 22, 2019Method For Preparing An Anhydrosugar Alcohol Using Hydrol1
EP2759294
Nov 1, 2017Percutaneously Absorbable Preparation Containing Fentanyl And A Homologue Thereof1

Latest PTAB cases involving Samyang

Discover the latest PTAB cases involving Samyang, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Samyang with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 9, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
SAMYANG BIOPHARMACEUTICALS - 1 - - Non-Active
HEXAL573 - - Highly Aggressive